Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Youji Feng

Showing results (11-20 of 68) with videos related to

Pageof 7
Sort By:
Molecular Cancer|November 18, 2009
Elevated expression of p53 gain-of-function mutation R175H in endometrial cancer cells can increase the invasive phenotypes by activation of the EGFR/PI3K/AKT pathwayPeixin Dong, Zhujie Xu, Nan Jia, et al.
Gynecologic Oncology|January 24, 2007
Epidermal growth factor receptor signaling enhanced by long-term medroxyprogesterone acetate treatment in endometrial carcinomaShujun Zhao, Xiaojun Chen, Xin Lu, et al.
Cancer Genetics and Cytogenetics|June 9, 2007
Down-regulation of the progesterone receptor by the methylation of progesterone receptor gene in endometrial cancer cellsYun Ren, Xishi Liu, Duan Ma, et al.
Cancer Biomarkers : Section a of Disease Markers|June 18, 2016
Neutrophil to lymphocyte ratio and platelet to lymphocyte ratio are predictive of chemotherapeutic response and prognosis in epithelial ovarian cancer patients treated with platinum-based chemotherapyYi Miao, Qin Yan, Shuangdi Li, et al.
Oncology Research|March 11, 2017
Inhibition of Proliferation, Migration, and Invasion by Knockdown of Pyruvate Kinase-M2 (PKM2) in Ovarian Cancer SKOV3 and OVCAR3 CellsYi Miao, Meng Lu, Qin Yan, et al.
Oncology Research|May 1, 2016
RNAi-Mediated Downregulation of FKBP14 Suppresses the Growth of Human Ovarian Cancer CellsMeng Lu, Yi Miao, Lan Qi, et al.
The Journal of Obstetrics and Gynaecology Research|May 1, 2012
Metformin sensitizes endometrial cancer cells to chemotherapy by repressing glyoxalase I expressionLingling Dong, Qian Zhou, Zhenbo Zhang, et al.
Oncology Reports|August 30, 2011
Re-expression of estrogen receptor β inhibits the proliferation and migration of ovarian clear cell adenocarcinoma cellsJing Zhu, Keqin Hua, Hong Sun, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|March 9, 2019
Metformin sensitizes endometrial cancer cells to progestin by targeting TET1 to downregulate glyoxalase I expressionYanyu Jiang, Xiong Chen, Youheng Wei, et al.
Biochemical and Biophysical Research Communications|April 26, 2015
OCT4 mediates FSH-induced epithelial-mesenchymal transition and invasion through the ERK1/2 signaling pathway in epithelial ovarian cancerLei Liu, Jing Zhang, Chi Fang, et al.
Pageof 7

Showing results (11-20 of 68) with videos related to

Sort By:
Pageof 7
Molecular Cancer|November 18, 2009
Elevated expression of p53 gain-of-function mutation R175H in endometrial cancer cells can increase the invasive phenotypes by activation of the EGFR/PI3K/AKT pathwayPeixin Dong, Zhujie Xu, Nan Jia, et al.
Gynecologic Oncology|January 24, 2007
Epidermal growth factor receptor signaling enhanced by long-term medroxyprogesterone acetate treatment in endometrial carcinomaShujun Zhao, Xiaojun Chen, Xin Lu, et al.
Cancer Genetics and Cytogenetics|June 9, 2007
Down-regulation of the progesterone receptor by the methylation of progesterone receptor gene in endometrial cancer cellsYun Ren, Xishi Liu, Duan Ma, et al.
Cancer Biomarkers : Section a of Disease Markers|June 18, 2016
Neutrophil to lymphocyte ratio and platelet to lymphocyte ratio are predictive of chemotherapeutic response and prognosis in epithelial ovarian cancer patients treated with platinum-based chemotherapyYi Miao, Qin Yan, Shuangdi Li, et al.
Oncology Research|March 11, 2017
Inhibition of Proliferation, Migration, and Invasion by Knockdown of Pyruvate Kinase-M2 (PKM2) in Ovarian Cancer SKOV3 and OVCAR3 CellsYi Miao, Meng Lu, Qin Yan, et al.
Oncology Research|May 1, 2016
RNAi-Mediated Downregulation of FKBP14 Suppresses the Growth of Human Ovarian Cancer CellsMeng Lu, Yi Miao, Lan Qi, et al.
The Journal of Obstetrics and Gynaecology Research|May 1, 2012
Metformin sensitizes endometrial cancer cells to chemotherapy by repressing glyoxalase I expressionLingling Dong, Qian Zhou, Zhenbo Zhang, et al.
Oncology Reports|August 30, 2011
Re-expression of estrogen receptor β inhibits the proliferation and migration of ovarian clear cell adenocarcinoma cellsJing Zhu, Keqin Hua, Hong Sun, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|March 9, 2019
Metformin sensitizes endometrial cancer cells to progestin by targeting TET1 to downregulate glyoxalase I expressionYanyu Jiang, Xiong Chen, Youheng Wei, et al.
Biochemical and Biophysical Research Communications|April 26, 2015
OCT4 mediates FSH-induced epithelial-mesenchymal transition and invasion through the ERK1/2 signaling pathway in epithelial ovarian cancerLei Liu, Jing Zhang, Chi Fang, et al.
Pageof 7